Disclaimer
This information collection is a core HTA, i.e. an extensive analysis of one or more health technologies using all nine domains of the HTA Core Model. The core HTA is intended to be used as an information base for local (e.g. national or regional) HTAs.

Structured telephone support (STS) for adult patients with chronic heart failure

Structured telephone support (STS) for adult patients with chronic heart failure compared to Usual care defined as regular schedules of visits of the patient at the heart center/ GP/cardiologist or patient has to move (≠ at home) in the prevention of Chronic cardiac failure in adults and elderly with chronic heart failure (CHF) AND hospitalization due to heart failure at least once AND without implanted devices

(See detailed scope below)

HTA Core Model Application for Medical and Surgical Interventions (2.0)
Core HTA
Published
Tom Jefferson (Agenas - Italy), Marina Cerbo (Agenas - Italy), Nicola Vicari (Agenas - Italy)
Neill Booth (THL - Finland), Plamen Dimitrov (NCPHA - Bulgaria), Mirjana Huic (AAZ - Croatia), Valentina Rupel (IER - Slovenia), Alessandra Lo Scalzo (Agenas - Italy), Ingrid Wilbacher (HVB - Austria)
Agenas - Agenzia nazionale per i servizi sanitari regionali
AAZ (Croatia), Agenas (Italy), ASSR RER (Italy), Avalia-t (Spain), CEM (Luxembourg), GÖG (Austria), HVB (Austria), IER (Slovenia), ISC III (Spain), NCPHA (Bulgaria), NIPH (Slovenia), NSPH (Greece), NSPH MD (Romania), SBU (Sweden), SNHTA (Switzerland), THL (Finland), UTA (Estonia).
9.9.2014 11.18.00
4.12.2015 17.51.00
Jefferson T, Cerbo M, Vicari N [eds.]. Structured telephone support (STS) for adult patients with chronic heart failure [Core HTA], Agenas - Agenzia nazionale per i servizi sanitari regionali ; 2015. [cited 13 December 2019]. Available from: http://meka.thl.fi/ViewCover.aspx?id=305

Structured telephone support (STS) for adult patients with chronic heart failure

<< Health Problem and Current Use of the TechnologySafety >>

Description and technical characteristics of technology

Authors: Ingrid Wilbacher, Valentina Prevolnik Rupel

Summary

TEC1: Who manufactures Telemonitoring in home care for patients with chronic cardiovascular diseases?

We did not answer this question in the TEC domain. Please find the overlapping results in CUR_ 15

TEC2: What kind of qualification and quality assurance processes are needed for the use or maintenance of Telemonitoring in home care for patients with chronic cardiovascular diseases?

The answer was created out of statements in nine of the included studies from the general literature search and an additional unstructured search in google for more information.

The studies providing information about the staff qualification mainly content of

-management according to a multidisciplinary/ physicians care plan

-provision of monitoring and reaction in case of abnormities by nurses

The results of the survey with 15 experts in Germany {1} provide a conclusive overview of expected skills:

-methodological competence (analytical thinking, ability of reflexion, autonomy, linguistic, anamnestic competence, ability of abstraction, ability of reaction)

-social competence (empathy, communication skills, politeness, social sensitivity, authority, motivation skills, kindness)

-professionality (basic medical knowledge, secure technical skills, practical medicinal experience, knwoledge of basic health legislation, knwoledge about the health system, psychological motivational skills, knowledge in quality management)

-personal competence (self-knowledge, psychical capacity, steadiness, distress-resistancy, learning motivation, professional distance, IT-skills)

Structural quality:

-How telemonitoring or telemedicine is implemented and to whom varies (see also CUR and LEG domain).

Process quality:

-The quality assurance seems to be lacking.

 

TEC3: What kind of training and information should be provided for the patient who uses Telemonitoring in home care for patients with chronic cardiovascular diseases, or for his family?

In the ten included studies for this question the following training/ patient education aspects were adressed:

1. General heart failure education

-detection of deterioration

-use of medication

-diet

-physcial activity/ exercise training

-Smoking cessation

2.telemonitoring specific training

-training to use devices (technically)

-training to manage the information (empowerment and self-care), interpret the vital signals and efficiently utilize them

3.Other training/ education

-coping with difficult emotions

-relaxation and cognitive symptom management techniques

-lifestyle aspects: alcohol intake, sexual activity

-necessity of vaccinations

-capabilities of patients to travel or work

-coping with individual problems, often related to comorbid conditions

-training of relatives/ caregivers

How is the training suggested to be provided:

-could be carried out in groups of 10-15 people, where patients can assist and help each other

-through leaflets and online manuals, depending on the service

TEC4: What information of Telemonitoring in home care for patients with chronic cardiovascular diseases should be provided for patients outside the target group and the general public?

Information to patients outside the target group and the general public should therefore focus on the reasons and the explanaition for inclusion or exclusion of people/ patients for access to structured telephone support. People should be informed that structured telephone support is not suitable for all individuals nor is it appropriate under all medical circumstances

TEC5: What is Telemonitoring in home care for patients with chronic cardiovascular diseases and the comparator(s)?

 

The non-invasive telemedicine/telemonitoring contains the following aspects (seperately or combined):

-remote access control (transfer of physiological data)

-nurse-led management program after hospital discharge

-disease management program (including cardiologists, nurses, GPs)

-patient education

-regular outpatient contact

-self-care supportive strategies

-case management interventions

-monitoring and (daily) transmission of vital parameters and weight

-telephone-follow up

-home-visits

-remote consultation with a nurse by video-camera

-weigh daily and respond to questions concerning heart failure symptoms

-daily data-transfer to a secure Internet site

-response to questions from a computerized interactive voice response system

-medication management (adherence),

-fluid management (adherence)

-problem solving

-exercise recommendation

-diet adeherence

-goal setting

-structured telephone support

-human-to-human contact (HH) or human-to-machine interface (HM)

 

Usual care

-standard post-discharge care without intensified attendance at cardiology clinics

-clinic-based CHF disease management programme

-home visiting

There is no consensus definition of the fundamental terms utilized.

There is also an „upcoming“ topic called mHealth meaning mobile health through mobile phones and similar devices using software applications (apps). There is increasing interest on mhealth, especially with the hope of easy and equal acces for information, tele-diagnostic or –care aspects and data collection and use for health purpose. Some major aspects are to be worked out (like network issues, data security, information quality, legal and regulatory aspects etc.) and are aim within the EU horizon 2020.

TEC6: In what context and level of care are Telemonitoring in home care for patients with chronic cardiovascular diseases and the comparator used?

Conclusion: telemedicine/ telemonitoring interventions can be used in all different settings (outpatient, outpatient clinic, hospital based, home, mixed setting), they are mainly provided in outpatient organisations, the most important part ist the additional setting at the patients‘ home.

TEC7: Are the reference values or cut-off points clearly established?

The reference values for heart failure diagnostic (- monitoring) are mainly a) mortality and b) hospitalisation (rate).

There are more clearly established results for the diagnostic accuracy within monitoring the implantable device-based indicators, alone or combined with weight and symptoms.

 

The reference values used for telemedical approaches with structured interviews are more or less standardized (like in www. klinik.uni-wuerzburg.de/medizin1/inh-heartnetcarehf { Rec #: 200}, but there is also a subjective category which cannot be clear established, like „listening into a patients‘ kind of reporting“, „detecting differences within a knwon patient“, that require a human sense approach.

The reference value of „mortality“ and „hospitalisation“ requires a competent listening/ monitoring person who decides when the emergency chain has to be initiated.

TEC8: What material investments are needed to use Telemonitoring in home care for patients with chronic cardiovascular diseases?

Despite the implantable devices, further materials are needed for telemonitoring/ telemedicine:

Patients home

-patient near unit (funk transmission)

-telephone/ cell phone with telephone line

-scale

-camera

-PC with internet

Data transfer

-Secure data sending line (internet)

-Telephone line

-Secured technical interoperability/ adaptiveness

Receiver of data/ care center/ nurse

-PC, software

-Telephone

-Usual office infrastructure

-Ev. car for home visits

There is a need for further research in knowledge representation, and the used data analysis methods. Current barriers for adaptation include uncertainty about the response protocols, payment systems, and prescribing protocols. {29}

TEC9: What kind of special premises are needed to use Telemonitoring in home care for patients with chronic cardiovascular diseases and the comparator(s)?

No special premises were found in the literature.

TEC10: What equipment and supplies are needed to use Telemonitoring in home care for patients with chronic cardiovascular diseases and the comparator?

We provide the answer within TEC 8

TEC11: What kind of data and records are needed to monitor the use of Telemonitoring in home care for patients with chronic cardiovascular diseases and the comparator?

The needs for a sustainable telemonitoring include

-Qualified professionals (human resources) doing the monitoring/ statistics/emergency prioritisation

-Economic resources to provide the infrastructure for data transmission (GSM network, analogue phoneline, internet, software) and telephone support, documentation, home visits, etc.

-Transparent selection of patients who benefit best

TEC12: What kind of registers are needed to monitor the use Telemonitoring in home care for patients with chronic cardiovascular diseases and comparator?

There are no specific registries to monitor or register the use of structured telephone support  for heart failure specifically. If a national registry is already existing and/or the EU registry is used/ planned to be used there needs to be no further register installed for telemonitoring in heart failure patients.

The telemonitoring aspects – at least „on telemonitoring yes/no“, what kind of telemonitoring is used, entry-exit date – can be easily added into an existing registry.

Introduction

In this domain we aim to explain what is meant by „structured telephone support (STS) within telemonitoring“, to detect whether „telemedicine“ means the same as „telemonitoring“or something different, what wordings and explanations are currently in use and what do they mean.  We aim to describe the forms of existing telemonitoring technologies, their use and functioning as well as major issues that stem from the use of these technologies. Also exsposed are the preconditions for the use of telemonitoring, educational needs on the side of patients and families as well as professional teams. Regarding the use of telemonitoring all forms of telemonitoring devices are categorized according to their settings etc. The reference values that trigger the interventions are looked into and material investments as well as necessary equipment and supplies for the use of telemonitoring by STS are researched. The registers are listed to monitor the use of the technology and comparator. 

Methodology

Frame

The collection scope is used in this domain.

TechnologyStructured telephone support (STS) for adult patients with chronic heart failure
Description

Telemonitoring via structured telephone support with focus on patient reported signs (symptoms of congestion, peripheral edema, pulmonary congestion, dyspnea on exertion, abdominal fullness), medication adherence, physiological data (like heart rate, blood pressure, body weight – measured by the patient with home-device), activity level; done in regular schedules using risk stratification (with fixed algorithm by call center staff or experience-based by specialized staff); done by dedicated call centers, center-based staff, nurses, AND reduced visits to a GP or heart center

Intended use of the technologyPrevention

Remote transmission of information to alleviate symptoms, relieve suffering and allow timely treatment for chronic heart failure

Target condition
Chronic cardiac failure
Target condition description

Heart failure is a condition in which the heart has lost the ability to pump enough blood to the body's tissues. With too little blood being delivered, the organs and other tissues do not receive enough oxygen and nutrients to function properly.

Target population

Target population sex: Any. Target population age: adults and elderly. Target population group: Patients who have the target condition.

Target population description

Patients with chronic heart failure (CHF; defined as I50 http://www.icd10data.com/ICD10CM/Codes/I00-I99/I30-I52/I50-/I50 ) AND hospitalization due to heart failure at least once  AND without implanted devices

ComparisonUsual care defined as regular schedules of visits of the patient at the heart center/ GP/cardiologist or patient has to move (≠ at home)
Description

Usual care defined as regular schedules of visits of the patient at the heart center/ GP/cardiologist; patient has to move (≠ at home)

Outcomes

Mortality (disease specific and all cause) progressions, admissions, re-admissions, QoL or HRQoL, harms

Assessment elements

TopicIssue RelevantResearch questions or rationale for irrelevance
A0022OtherWho manufactures the technology?yesWho manufactures structured telephone support (STS) for adult patients with chronic heart failure?
B0012Training and information needed to use the technologyWhat kind of qualification and quality assurance processes are needed for the use or maintenance of the technology?yesWhat kind of qualification and quality assurance processes are needed for the use or maintenance of Structured telephone support (STS) for adult patients with chronic heart failure?
B0014Training and information needed to use the technologyWhat kind of training and information should be provided for the patient who uses the technology, or for his family?yesWhat kind of training and information should be provided for the patient who uses Structured telephone support (STS) for adult patients with chronic heart failure, or for his family?
B0015Training and information needed to use the technologyWhat information of the technology should be provided for patients outside the target group and the general public?yesWhat information of Structured telephone support (STS) for adult patients with chronic heart failure should be provided for patients outside the target group and the general public?
B0013Training and information needed to use the technologyWhat kind of training and information is needed for the personnel/carer using this technology?yes
B0001Features of the technologyWhat is this technology and the comparator(s)?yesWhat is Structured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?
B0005Features of the technologyIn what context and level of care are the technology and the comparator used?yesIn what context and level of care are Structured telephone support (STS) for adult patients with chronic heart failure and the comparator used?
B0018Features of the technologyAre the reference values or cut-off points clearly established?yesAre the reference values or cut-off points clearly established?
B0002Features of the technologyWhat is the approved indication and claimed benefit of the technology and the comparator(s)?noThis is overlapping with the CUR domain and will be answered there. The indication is selected within the PICO definition
B0003Features of the technologyWhat is the phase of development and implementation of the technology and the comparator(s)?noThis overlaps with the "management" in the CUR domain and will be answered there
B0004Features of the technologyWho performs or administers the technology and the comparator(s)?noThis overlaps with the "management" in the CUR domain and will be answered there
B0007Investments and tools required to use the technologyWhat material investments are needed to use the technology?yesWhat material investments are needed to use Structured telephone support (STS) for adult patients with chronic heart failure?
B0008Investments and tools required to use the technologyWhat kind of special premises are needed to use the technology and the comparator(s)?yesWhat kind of special premises are needed to useStructured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?
B0009Investments and tools required to use the technologyWhat equipment and supplies are needed to use the technology and the comparator?yesWhat equipment and supplies are needed to use Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?
B0010Investments and tools required to use the technologyWhat kind of data and records are needed to monitor the use of the technology and the comparator?yesWhat kind of data and records are needed to monitor the use of Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?
B0011Investments and tools required to use the technologyWhat kind of registers are needed to monitor the use the technology and comparator?yesWhat kind of registers are needed to monitor the use Structured telephone support (STS) for adult patients with chronic heart failure and comparator?

Methodology description

Domain frame

To answer the questions in the assessment elements we mainly used the basic literature search provided for the whole project. For some answers additional handsearch was used, and for some AEs we did a google search in other resources than scientific literature (i.e. for TEC_11).

The extracted studies and the reason for not using them is provided in the annex 1 at the end of the domain report. The issue (research question) specific methods will be reported later in the methods field of the result card.

Information sources

Common basic project literature search

Handsearch (additional reference found/ provided)

Google (for registries)

Quality assessment tools or criteria

We did not rate the quality of the included studies, but mentioned whether the information was extracted from systematic reviews or single studies (i.e. RCTs) or other resources.

Analysis and synthesis

Two investigators divided the amount of studies by alphabeth, each scanned the half of the studies and double-checked the other.

Result cards

Other

Result card for TEC1: "Who manufactures structured telephone support (STS) for adult patients with chronic heart failure?"

View full card
TEC1: Who manufactures structured telephone support (STS) for adult patients with chronic heart failure?
Result

Importance: Unspecified

Transferability: Unspecified

Training and information needed to use the technology

Result card for TEC2: "What kind of qualification and quality assurance processes are needed for the use or maintenance of Structured telephone support (STS) for adult patients with chronic heart failure?"

View full card
TEC2: What kind of qualification and quality assurance processes are needed for the use or maintenance of Structured telephone support (STS) for adult patients with chronic heart failure?
Method
Short Result
Result

Importance: Critical

Transferability: Partially

Result card for TEC3: "What kind of training and information should be provided for the patient who uses Structured telephone support (STS) for adult patients with chronic heart failure, or for his family?"

View full card
TEC3: What kind of training and information should be provided for the patient who uses Structured telephone support (STS) for adult patients with chronic heart failure, or for his family?
Method
Short Result
Result

Importance: Critical

Transferability: Completely

Result card for TEC4: "What information of Structured telephone support (STS) for adult patients with chronic heart failure should be provided for patients outside the target group and the general public?"

View full card
TEC4: What information of Structured telephone support (STS) for adult patients with chronic heart failure should be provided for patients outside the target group and the general public?
Method
Short Result
Result

Importance: Critical

Transferability: Completely

Features of the technology

Result card for TEC5: "What is Structured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?"

View full card
TEC5: What is Structured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?
Method
Result
Comment

Importance: Critical

Transferability: Completely

Result card for TEC6: "In what context and level of care are Structured telephone support (STS) for adult patients with chronic heart failure and the comparator used?"

View full card
TEC6: In what context and level of care are Structured telephone support (STS) for adult patients with chronic heart failure and the comparator used?
Method
Short Result
Result

Importance: Important

Transferability: Completely

Result card for TEC7: "Are the reference values or cut-off points clearly established?"

View full card
TEC7: Are the reference values or cut-off points clearly established?
Method
Short Result
Result

Importance: Important

Transferability: Completely

Investments and tools required to use the technology

Result card for TEC8: "What material investments are needed to use Structured telephone support (STS) for adult patients with chronic heart failure?"

View full card
TEC8: What material investments are needed to use Structured telephone support (STS) for adult patients with chronic heart failure?
Method
Short Result
Result

Importance: Important

Transferability: Completely

Result card for TEC9: "What kind of special premises are needed to useStructured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?"

View full card
TEC9: What kind of special premises are needed to useStructured telephone support (STS) for adult patients with chronic heart failure and the comparator(s)?
Result

Importance: Unspecified

Transferability: Unspecified

Result card for TEC10: "What equipment and supplies are needed to use Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?"

View full card
TEC10: What equipment and supplies are needed to use Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?
Result

Importance: Unspecified

Transferability: Unspecified

Result card for TEC11: "What kind of data and records are needed to monitor the use of Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?"

View full card
TEC11: What kind of data and records are needed to monitor the use of Structured telephone support (STS) for adult patients with chronic heart failure and the comparator?
Method
Short Result
Result

Importance: Important

Transferability: Partially

Result card for TEC12: "What kind of registers are needed to monitor the use Structured telephone support (STS) for adult patients with chronic heart failure and comparator?"

View full card
TEC12: What kind of registers are needed to monitor the use Structured telephone support (STS) for adult patients with chronic heart failure and comparator?
Method
Short Result
Result

Importance: Important

Transferability: Partially

Discussion

We found a wide range of interpretation of what is meant by telemonitoring/ telemedicine in the included literature. There are variations  of telemonitoring like disease management programs, hospital based external monitoring structure, data-transfer and reaction by staff and/or device, structured or unstructured telephone support and involvement of professionals (i.e. cardiologist, nurse, GP).

The non-invasive monitoring, which includes structured telephone support  gives the impression to be often implemented from „bottom up“ with therefore different solutions, contents and settings – as appropriate to the innovative bottom-up idea.

There is a need of  a structured care outside the hospital for patients who do not need continous in-hospital care but should be monitored for a sudden deterioration or emergency-situation.. The solution of a high-frequent GP contact is not feasible as the number of control visits would increase enormously due to increase in chronic diseases.  

The idea of a monitoring at distance saves time and efforts, but the solution seems to lack in structural and surrounding details like „whom to involve“, „how to train whom“ and „what should be done with the data“ (data security, data secure transfer, transmisson line system, etc.), influencing the studies outcomes.

We did not restrict the included studies in this TEC domain by study-methodology, because we wanted to have a valid description of projects and implemented system approaches for telemonitoring.

For structured telephone support it has to be taken into account

  • Who calls whom when for what

  • Who collects what data for what purpose

  • What happens with the data

  • Who reacts on the collected information and when and how

  • Is there a need of technical support or function maintainance

  • Is the target group of heart failure patients ready for the planned intervention (i.e. what kind of telephone are they able to use)

References

[1] Abraham WT, Adamson PB, Bourge RC, on behalf of the CHAMPION trial study group. Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: A randomised controlled trial. Lancet 2011;377:658-666. in Dubner S, Auricchio A, Steinberg JS et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17(1):36-56.

[2] AHRQ Hersh WR, Hickam DH, Severance SM, Dana TL, Krages KP, Helfand M. Telemedicine for the Medicare Population: Update. Evidence Report/Technology Assessment No. 131 (Prepared by the Oregon Evidence-based Practice Center under Contract No. 290-02-0024.) AHRQ Publication No. 06-E007. Rockville, MD: Agency for Healthcare Research and Quality. February 2006.

[3] Barth V. A nurse-managed discharge program for congestive heart failure patients: outcomes and costs. Home Health Care Manag Pract. 2001;(6):436–43. CN-00773514. in Feltner C., Jones C.D., Cene C.W. et al. Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis. Ann. Intern. Med. 2014; 160(11):774-84.

[4] Bourge RC, Abraham WT, Adamson PB, Aaron MF, Aranda JM Jr, Magalski A, Zile MR, Smith AL, Smart FW, O’Shaughnessy MA, Jessup ML, Sparks B, Naftel DL, Stevenson LW; COMPASS-HF Study Group. Randomized controlled trial of an implantable continous hemodynamic monitor in patients with advanced heart failure: the COMPASS-HF study. J Am Coll Cardiol 2008; 51: 1073-9. in Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[5] Casas J.P., Kwong J., Ebrahim S. Telemonitoring for chronic heart failure: not ready for prime time. Cochrane Database Syst Rev 2011; 2011:ED000008.

[6] Chaudhry SI, Phillips CO, Stewart SS et al. Telemonitoring for patients with chronic heart failure: a systematic review. J Card Fail 2007; 13(1):56-62.

[7] Ciere Y, Cartwright M, Newman SP. A systematic review of the mediating role of knowledge, self-efficacy and self-care behaviour in telehealth patients with heart failure. J Telemed Telecare 2012; 18(7):384-91.

[8] Clark A.L. Heart failure. Arch. Cardiol. Mex. 2011; 81(4):383-90.

[9] Clark RA, Inglis SC, McAlister FA, Cleland JG, Stewart S. Telemonitoring or structured telephone support programmes for patients with chronic heart failure: systematic review and meta-analysis. BMJ 2007; 334(7600):942.

[10] Clark R.A., Conway A., Inglis S.C., Horton-Breshears M., Cleland J.G.F. Not all systematic reviews are systematic: A meta-review of the quality of current systematic reviews and meta-analyses for remote monitoring in heart failure. Eur. J. Heart Fail. 2013; 12:S229.

[11] Clarke M, Shah A, Sharma U. Systematic review of studies on telemonitoring of patients with congestive heart failure: a meta-analysis. J Telemed Telecare 2011; 17(1):7-14.

[12] Cleland J.G.F., Coletta A.P., Buga L. et al. Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT. Eur. J. Heart Fail. 2011; 13(4):460-5.

[13] Cleland JG, Coletta AP, Clark AL. Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study. Eur J Heart Fail 2006; 8(6):658-61.

[14] Cleland JG, Louis AA, Rigby AS, Janssens U, Balk HM; TEN-HMS Investigators. Noninvasive home telemonitoring for patients with heart failure at high risk of recurrent admission and death: the Trans-European Network-Home-Care Management System (TEN-HMS) Study. J Am Coll Cardiol 2005;45:1654-64. in Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[15] Costa-Lobos A, Riley JP, Cowie MR. Current and future technologies for remote monitoring in cardiology and evidence  from trial data. Future Cardiol 2012; 8(3):425-37.

[16] Comprehensive care in heart failure. Evid.-Based Healthc. Public Health 2005; 9(6):391-5.

[17] Conway A, Inglis SC, Clark RA. Effective technologies for noninvasive remote monitoring in heart failure. Telemed J E Health 2014; 20(6):531-8.

[18] Currell R, Urquhart C, Wainwright P, Lewis R. Telemedicine versus face to face patient care: effects on professional practice and health care outcomes. Cochrane Database of Systematic Reviews 2000, Issue 2. Art. No.: CD002098. DOI:10.1002/14651858.CD002098.

[19] Dar O, Riley J, Chapman C, Dubrey SW, Morris S, Rosen SD, Roughton M, Cowie MR. A randomized trial of home monitoring in a typical elderly heart failure population in North West London: results of the Home-HF study. Eur J Heart Fail 2009; 11:319-25. in Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[20] Dubner S, Auricchio A, Steinberg JS et al. ISHNE/EHRA expert consensus on remote monitoring of cardiovascular implantable electronic devices (CIEDs). Ann Noninvasive Electrocardiol 2012; 17(1):36-56.

[21] Duffy JR, Hoskins LM, Chen MC. Nonpharmacological strategies for improving heart failure outcomes in the community: a systematic review. J Nurs Care Qual 2004; 19(4):349-60.

[22] Feltner C., Jones C.D., Cene C.W. et al. Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis. Ann. Intern. Med. 2014; 160(11):774-84.

[23] Farner A, Gibson OJ, Tarassenko L, Neil A. A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes. Diabet Med 22 (10) (2005) 1372-1378. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[24] Fye WB. Cardiology workforce: there’s already a shortage, and it’s getting worse!J Am Coll Cardiol. 2002;39:2077–2079. in Whellan D.J. Heart failure disease management: Implementation and outcomes. Cardiol. Rev. 2005; 13(5):231-9.

[25] Giamouzis G, Mastrogiannis D, Koutrakis K et al. Telemonitoring in chronic heart failure: a systematic review. Cardiol Res Pract 2012; 2012:410820.

[26] Gorthi J., Hunter C.B., Mooss A.N., Alla V.M., Hilleman D.E. Reducing heart failure hospital readmissions: A systematic review of disease management programs. Cardiol. Res. 2014; 5(5):126-38.

[27] Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[28] Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ. Cost-effectiveness of telehealth interventions for chronic heart failure patients: a literature review. Int J Technol Assess Health Care 2014; 30(1):59-68.

[29] Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[30] Hasan A, Paul V. Telemonitoring in chronic haéart failure. Novel devices. European Heart Journal (2011) 32. 1457-1464. DOI:10.1093/eurheartj/ehr005.

[31] Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure (Structured abstract).

[32] Inglis SC, Clark RA, McAlister FA, Stewart S, Cleland JG. Which components of heart failure programmes are effective? A systematic review and meta-analysis of the outcomes of structured telephone support or telemonitoring as the primary component of chronic heart failure management in 8323 patients: Abridged Cochrane Review. Eur J Heart Fail 2011; 13(9):1028-40.

[33] Inglis SC, Clark RA, McAlister FA et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst. Rev. 8, CD007228 (2010). in  Costa-Lobos A, Riley JP, Cowie MR. Current and future technologies for remote monitoring in cardiology and evidence  from trial data. Future Cardiol 2012; 8(3):425-37.

[34] Inglis S.C., Clark R.A., Cleland J.G.F., McAlister F., Stewart S. Structured telephone support or telemonitoring programs for patients with chronic heart failure. Cochrane Database Syst. Rev. 2008; (3).

[35] Institute of Medicine Glossary and AbbreviationsIn: Field MJ, editor. Telemedicine: A guide to assessing telecommunications in health care. Washington, DC: National Academy Press; 1996. pp. 239-252. in Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[36] Jaana M, Paré G, Sicotte C. Home telemonitoring for respiratory conditions: a systematic review. Am J Manag Care 15 (2009) 313-320. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[37] Jaarsma T., Brons M., Kraai I., Luttik M.L., Stromberg A. Components of heart failure management in home care; A literature review. Eur. J. Cardiovasc. Nurs. 2013; 12(3):230-41.

[38] Jackson CI, Bolen S, Brancati FL, Batts-Turner ML, Gary TL. A systematic revie of interactive computer-assisted technology in diabetes care. Interactive informations technology in diabetes care. J Gen Intern Med 21 (2) (2006) 105-110. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[39] Jerant A.F., Nesbitt T.S. Heart failure disease management incorporating telemedicine: A critical review. J. Clin. Outcomes Manage. 2005; 12(4):207-17.

[40] Klersy C., De Silvestri A., Gabutti G., Regoli F., Auricchio A. Telemonitoring in chronic heart failure: A meta-analysis. Eur. Heart J. 2009; 30:713.

[41] Koehler F, Winkler S, Schieber M, et al. Impact of remote telemedical management on mortality and hospitalizations in ambulatory patients with chronic heart failure: the telemedical interventional monitoring in heart failure study. Circulation. 2011;123(17):1873–1880. in Giamouzis G, Mastrogiannis D, Koutrakis K et al. Telemonitoring in chronic heart failure: a systematic review. Cardiol Res Pract 2012; 2012:410820.

[42] Krumholz HM, Amatruda J, Smith GL, Mattera JA, Roumanis SA, Radford MJ, Crombie P, Vaccarino V. Randomized trial of an eductaion and support intervention to prevent readmission of patients with heart failure. J Am Coll Cardiol 2002; 39:83-9.  in Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[43] Laramee AS, Levinsky SK, Sargent J, et al. Case management in a heterogeneous congestive heart failure population: a randomized controlled trial. Arch Intern Med. 2003 Apr 14;163(7):809–17. Epub: 2003/04/16.  in Feltner C., Jones C.D., Cene C.W. et al. Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis. Ann. Intern. Med. 2014; 160(11):774-84.

[44] Louis A, Turner T, Gretton M, Baksh A, Cleland J. A systematic review of telemonitoring for the management of heart failure Eur J Heart Fail 2003;5:583-590. in Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[45] Maric B, Kaan A, Ignaszewski A, Lear SA. A systematic review of telemonitoring technologies in heart failure. Eur J Heart Fail 2009; 11(5):506-17.

[46] Maric B, Kaan A, Ignaszewski A, Lear SA. A systematic review of telemonitoring technologies in heart failure. Eur J Heart Fail 11 (May (5)) (2009) 506-517. In {29}

[47] MAST REgioNs of Europe WorkINg toGether for HEALTH (Grant Agreement No 250487). D1.12 v1.5 Renewing Health Final Project Report

[48] May C, Mort M, Mair F, Williams T. Factors affecting the adoption of telehealthcare in the United Kingdom: the prolicy context and the problem of evidence. Health Informatics J 7 (September (3-4)) (2001) 131-134. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[49] Meystre S. The current state of telemonitoring: A comment on the literature Telemedicine and E-Health 2005;11:63-69.  in Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[50] Mosterd A, Hoes AW. Clinical epidemiology of heart failure. Heart 93 (September (9)) (2007) 1137-1146. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[51] Nüesch E, Trelle S, Reichenbach S, Rutjes AWS, Tschannen B, Altman DG, Egger M, Jüni P. Small study effects in meta-analysis of osteoarthritis trials: meta-epidemiological study. BMJ 2010;341:c3515-23. in Gurne O, Conraads V, Missault L et al. A critical review on telemonitoring in heart failure. Acta Cardiol 2012; 67(4):439-44.

[52] Radhakrishnan K, Jacelon C. Impact of telehealth on patient self-management of heart failure: a review of literature. J Cardiovasc Nurs 2012; 27(1):33-43.

[53] Pandor A, Thokala P, Gomersall T et al. Home telemonitoring or structured telephone support programmes after recent discharge in patients with heart failure: systematic review and economic evaluation. Health Technol Assess 2013; 17(32):1-207, v-vi.

[54] Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[55] Pare G, Moqadem K, Pineau G, St-Hilaire C. Clinical effects of home telemonitoring in the context of diabetes, asthma, heart failure and hypertension: a systematic review. J Med Internet Res 2010; 12(2):e21.

[56] Purcell R, McInnes S, Halcomb EJ. Telemonitoring can assist in managing cardiovascular disease in primary care: a systematic review of systematic reviews. BMC Fam Pract 2014; 15:43.

[57] Rich MW. Epidemiology, pathophysiology, and etiology of congestive heart failure in older adults. J Am Geriatr Soc. 1997;45:968 –974.in Whellan D.J. Heart failure disease management: Implementation and outcomes. Cardiol. Rev. 2005; 13(5):231-9.

[58] Riegel B, Carlson B, Kopp Z, et al. Effect of a standardized nurse case-management telephone intervention on resource use in patients with chronic heart failure. Arch Intern Med. 2002 Mar 25;162(6):705–12. Epub: 2002/03/26. in Feltner C., Jones C.D., Cene C.W. et al. Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis. Ann. Intern. Med. 2014; 160(11):774-84.

[59] Riegel B, Carlson B, Glaser D, et al. Randomized controlled trial of telephone case management in Hispanics of Mexican origin with heart failure. J Card Fail. 2006 Apr;12(3):211–9. Epub: 2006/04/21. in Feltner C., Jones C.D., Cene C.W. et al. Transitional care interventions to prevent readmissions for persons with heart failure: A systematic review and meta-analysis. Ann. Intern. Med. 2014; 160(11):774-84.

[60] Roine R, Ohinmaa A, Hailey D. Assessing telemedicine: A systematic review of the literature Can Med Assoc J 2001;165:765-771.  in Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[61] Scherr D, Kastner P, Kollmann A, et al. Effect of home-based telemonitoring using mobile phone technology on the outcome of heart failure patients after an episode of acute decompensation: randomized controlled trial. Journal of Medical Internet Research. 2009;11(3):p. e34.  in Giamouzis G, Mastrogiannis D, Koutrakis K et al. Telemonitoring in chronic heart failure: a systematic review. Cardiol Res Pract 2012; 2012:410820.

[62] Sousa C., Leite S., Lagido R., Ferreira L., Silva-Cardoso J., Maciel M.J. Telemonitoring in heart failure: A state-of-the-art review. Rev. Port. Cardiol. 2014.

[63] Stork S, Faller H, Schowalter M, Ertl G, Angermann CE. [Evidence-based disease management in patients with heart failure (HeartNetCare-HF Wurzburg)]. Dtsch Med Wochenschr 2009; 134(15):773-6.

[64] Vitacca M, Bianchi L, Guerra C, Fracchia C, Spanevello A, Balbi B et al. Tele-assistance in chronic respiratory failure patients: a randomised clinical trial. Eur Respir J 33 (February (2)) (2009) 411-418. In Hardisty AR, Peirce SC, Preece A et al. Bridging two translation gaps: a new informatics research agenda for telemonitoring of chronic disease. Int J Med Inform 2011; 80(10):734-44.

[65] Wakefield BJ, Boren SA, Groves PS, Conn VS. Heart failure care management programs: a review of study interventions and meta-analysis of outcomes. J Cardiovasc Nurs 2013; 28(1):8-19.

[66] Whellan D.J. Heart failure disease management: Implementation and outcomes. Cardiol. Rev. 2005; 13(5):231-9.

[67] Whellan DJ, Ousdigian KT, Al-Khatib SM et al. Combined heart failure device diagnostics identify patients at higher risk of subsequent heart failure hospitalizations.  J. Am. Coll. Cardiol. 55, 1803–1810 (2010). in Costa-Lobos A, Riley JP, Cowie MR. Current and future technologies for remote monitoring in cardiology and evidence  from trial data. Future Cardiol 2012; 8(3):425-37.

[68] Wootton R. Twenty years of telemedicine in chronic disease management--an evidence synthesis. J Telemed Telecare 2012; 18(4):211-20.

[69] Wainwright C, Wootton R. A review of telemedicine and asthma Dis Manag Health Outcomes 2003;11:557-563. in Pare G, Jaana M, Sicotte C. Systematic review of home telemonitoring for chronic diseases: the evidence base. J Am Med Inform Assoc 2007; 14(3):269-77.

[70] http://www.telemed-berlin.de/telemed/2010/beitrag/beitrag_budych317_391.pdf (last check on 24th of March 2015)

[71] Willey RM. Managing heart failure: a critical appraisal of the literature. J Cardiovasc Nurs 2012; 27(5):403-17.

[72] Clark A.L. Heart failure. Arch. Cardiol. Mex. 2011; 81(4):383-90.

[73] Adibi, Sasan, ed. (February 19, 2015). Mobile Health: A Technology Road Map. Springer. ISBN 978-3-319-12817-7 at http://en.wikipedia.org/wiki/MHealth

[74] Cipresso, P.; Serino S.; Villani D.; Repetto C.; Selitti L.; Albani G.; Mauro A.; Gaggioli A.; Riva G. (2012). "Is your phone so smart to affect your states? An exploratory study based on psychophysiological measures". Neurocomputing 84: 23–30. doi:10.1016/j.neucom.2011.12.027 at http://en.wikipedia.org/wiki/MHealth

[75] Germanakos P., Mourlas C., & Samaras G. "A Mobile Agent Approach for Ubiquitous and Personalized eHealth Information Systems" Proceedings of the Workshop on 'Personalization for e-Health' of the 10th International Conference on User Modeling (UM'05). Edinburgh, July 29, 2005, pp. 67–70. At http://en.wikipedia.org/wiki/MHealth

 [76] http://ec.europa.eu/digital-agenda/en/news/green-paper-mobile-health-mhealth

[77] IDC "Worldwide and U.S. Mobile Applications, Storefronts, Developer, and In-App Advertising 2011-

2015 Forecast: Emergence of Postdownload Business Models". In Green Paper on mobile health, available at http://ec.europa.eu/digital-agenda/en/news/green-paper-mobile-health-mhealth

[78] Deloitte study "mHealth in an mWorld", 2012. In [6]

 [79] Cloud computing refers to the storing, processing and use of data on remotely located computers

accessed over the internet. In [6]

[80] COM(2012) 529, "Unleashing the Potential of Cloud Computing in Europe", 27.09.2012. In [6]

 [81] Special Eurobarometer 381 E-COMMUNICATIONS HOUSEHOLD SURVEY, June 2012. In [6]

[82] http://ec.europa.eu/digital-agenda/en/connected-continent-legislative-package. In [6]

[83] The new EU funding programme for research and innovation for the period 2014-2020. In [6]

[84] Research2Guidance (2013), "The mobile health global market report 2013-2017: the commercialisation

of mHealth apps" (Vol. 3). In [6]

Appendices

Annex 1

Excluded literature from the basic literature search

Source

EndNote Number

P People aged 16 or more with CHF (defined as I50

I Home telemonitoring (defined as domiciliary detection, recognition, identification, location and transmission of vital functions and other biological information of a person )

C No home telemonitoring

O Mortality (disease specific and all cause) progressions, admissions, re-admissions, QoL, harms, device use

D Evidence synthesis studies (SRs, HTA reports) [updating RCTs i.e. RCT fitting the PICO which have been published after the last search date of the latest SR/HTA document ]

CUR_TEC domain?

other reason for exclusion

Mair F.S. Does remote monitoring improve outcome in patients with chronic heart failure? Commentary. Nat. Clin. Pract. Cardiovasc. Med. 2007; 4(11):588-9.

Rec #: 1260

 

 

 

 

no

 

 

Redman B.K. Ethically problematic assumptions regarding patient self management and barriers to improved outcomes. Expert Rev. Pharmacoecon. Outcomes Res. 2006; 6(5):489-94.

Rec #: 1450

 

 

 

 

 

no

 

Costa A.P., Hirdes J.P. Clinical characteristics and service needs of alternate-level-of-care patients waiting for long-term care in Ontario hospitals. Healtc. Policy 2010; 6(1):32-46. Rec #: 1400

Rec #: 1400

 

no

 

 

 

 

 

Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension 2011; 57(1):29-38.

Rec #: 460

no

 

 

 

 

 

 

Mengden T, Ewald S, Kaufmann S, vor dem Esche J, Uen S, Vetter H. Telemonitoring of blood pressure self measurement in the OLMETEL study. Blood Press Monit 2004; 9(6):321-5.

Rec #: 650

no

 

 

 

 

 

 

Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens 2013; 31(3):455-67; discussion 467-8.

Rec #: 380

no

 

 

 

 

 

 

Omboni S, Guarda A. Impact of home blood pressure telemonitoring and blood pressure control: a meta-analysis of randomized controlled studies. Am J Hypertens 2011; 24(9):989-98.

Rec #: 450

no

 

 

 

 

 

 

Parati G, de Leeuw P, Illyes M et al. Blood pressure measurement in research. Blood Press Monit 2002; 7(1):83-7.

Rec #: 670

no

 

 

 

 

 

 

Shepperd S. Hospital at home: The evidence is not compelling. Ann. Intern. Med. 2005; 143(11):840-1.

Rec #: 1470

 

 

 

 

no

 

 

Zartner P, Handke R, Photiadis J, Brecher AM, Schneider MB. Performance of an autonomous telemonitoring system in children and young adults with congenital heart diseases. Pacing Clin Electrophysiol 2008; 31(10):1291-9.

Rec #: 600

no

 

 

 

 

 

 

Jaana M, Pare G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract 2007; 13(2):242-53.

Rec #: 620

no

 

 

 

 

 

 

Baztan J.J., Suarez-Garcia F.M., Lopez-Arrieta J., Rodriguez-Manas L., Rodriguez-Artalejo F. Effectiveness of acute geriatric units on functional decline, living at home, and case fatality among older patients admitted to hospital for acute medical disorders: Meta-analysis. BMJ (Online) 2009; 338(7690):334-6.

Rec #: 1440

 

no

 

 

 

 

 

Crawford-Faucher A. Home- and center-based cardiac rehabilitation equally effective. Am. Fam. Phys. 2010; 82(8):994-5.

Rec #: 1390

 

no

 

 

 

 

 

Hwang R, Redfern J, Alison J. A narrative review on home-based exercise training for patients with chronic heart failure (Provisional abstract). Physical Therapy Reviews .

Rec #: 890

 

no

 

 

 

 

 

Hwang R., Marwick T. Efficacy of home-based exercise programmes for people with chronic heart failure: A meta-analysis. Eur. J. Cardiovasc. Prev. Rehabil. 2009; 16(5):527-35.

Rec #: 1420

 

no

 

 

 

 

 

Daskalopoulou SS, Khan NA, Quinn RR et al. The 2012 Canadian hypertension education program recommendations for the management of hypertension: blood pressure measurement, diagnosis, assessment of  risk, and therapy. Can J Cardiol 2012; 28(3):270-87.

Rec #: 740

no

 

 

 

 

 

 

McKinstry B, Hanley J, Wild S et al. Telemonitoring based service redesign for the management of uncontrolled hypertension: multicentre randomised controlled trial. BMJ 2013; 346:f3030.

Rec #: 360

no

 

 

 

 

 

 

Inglis Sally C, Clark Robyn A, McAlister Finlay A et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database of Systematic Reviews . CD007228

Rec #: 780

 

 

 

 

 

 

double

Feltner C, Jones CD, Cene CW et al. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med 2014; 160(11):774-84.

Rec #: 10

 

 

 

 

 

 

double

Chien C L, Lee C M, Wu Y W, Chen T A, Wu Y T. Home-based exercise increases exercise capacity but not quality of life in people with chronic heart failure: a systematic review (Structured abstract). Australian Journal of Physiotherapy .

Rec #: 900

 

no

 

 

 

 

 

Taylor Rod S, Dalal Hayes, Jolly Kate, Moxham Tiffany, Zawada Anna. Home-based versus centre-based cardiac rehabilitation. Cochrane Database of Systematic Reviews .

Rec #: 930

 

no

 

 

 

 

 

Chaudhry S.I., Phillips C.O., Stewart S.S. et al. Telemonitoring for Patients With Chronic Heart Failure: A Systematic Review. J. Card. Fail. 2007; 13(1):56-62.

Rec #: 1300

 

 

 

 

 

 

double

Samartzis L., Dimopoulos S., Tziongourou M., Nanas S. Effect of psychosocial interventions on quality of life in patients with chronic heart failure: A meta-analysis of randomized controlled trials. J. Card. Fail. 2013; 19(2):125-34.

Rec #: 1040

 

 

 

 

 

no

 

Clark R.A., Inglis S.C., Mcalister F.A. et al. Remote (non-invasive) monitoring in heart failure: Effect on length of stay, quality of life, knowledge, adherance and satisfaction in 8,323 heart failure patients: A systematic review. Eur. Heart J. 2010; 31:944-5.

Rec #: 1190

 

 

 

 

 

no

 

Clark R.A., Inglis S.C., Mcalister F.A. et al. Results from a systematic review and meta-analysis of remote (non-invasive) monitoring in 8,323 heart failure patients on length of stay, quality of life, knowledge, compliance and satisfaction. Eur. J. Heart Fail. Suppl. 2010; 9:S51-S52.

Rec #: 1210

 

 

 

 

 

no

 

Clark A.M., Spaling M., Harkness K. et al. Determinants of effective heart failure self-care: A systematic review of patients' and caregivers' perceptions. Heart 2014; 100(9):716-21.

Rec #: 1330

 

 

 

 

 

no

 

Kraai I.H., Luttik M.L.A., De Jong R.M. et al. Measuring patient satisfaction of heart failure patients with telemonitoring: A systematic review. Eur. J. Cardiovasc. Nurs. 2011; 10:S31.

Rec #: 1160

 

 

 

 

 

no

 

Aballea S., Verpillat P., Neine M.-E., Goryakin Y., Toumi M. Development of a model predicting the medico-economic impact of telemonitoring for patients with heart failure in france. Pharmacoepidemiol. Drug Saf. 2012; 21:16.

Rec #: 1100

 

 

 

 

 

no

 

Brennan A., Thokala P., Baalbaki H., Stevens J.W., Wang J., Pandor A. Telemonitoring after discharge with heart failure-costeffectiveness modelling of alternative service designs. Value Health 2012; 15(7):A360.

Rec #: 1090

 

 

 

 

 

no

 

Burri H, Sticherling C, Wright D, Makino K, Smala A, Tilden D. Cost-consequence analysis of daily continuous remote monitoring of implantable cardiac defibrillator and resynchronization devices in the UK. Europace 2013; 15(11):1601-8.

Rec #: 60

 

 

 

 

 

no

 

Klersy C, De Silvestri A, Gabutti G et al. Economic impact of remote patient monitoring: an integrated economic model derived from a meta-analysis of randomized controlled trials in heart failure. Eur J Heart Fail 2011; 13(4):450-9.

Rec #: 150

 

 

 

 

 

no

 

Thokala P., Baalbaki H., Brennan A. Telemonitoring after discharge from hospital with heart failure - Cost-effectiveness modelling of alternative service designs. Value Health 2013; 16(7):A530.

Rec #: 1000

 

 

 

 

 

no

 

Thokala P., Brennan A., Baalbaki H. Cost-effectiveness modelling of telemonitoring after discharge from hospital with heart failure. Value Health 2013; 16(3):A290.

Rec #: 1030

 

 

 

 

 

no

 

Conway A, Inglis SC, Chang AM, Horton-Breshears M, Cleland JG, Clark RA. Not all systematic reviews are systematic: a meta-review of the quality of systematic reviews for non-invasive remote monitoring in heart failure. J Telemed Telecare 2013; 19(6):326-37.

Rec #: 20

other source

 

 

 

 

 

double with Rec#1020

Feltner C, Jones CD, Cene CW et al. 2014. Transitional care interventions to prevent readmissions for persons with heart failure: a systematic review and meta-analysis. Ann Intern Med. 2014 Jun 3;160(11):774-84. doi: 10.7326/M14-0083.

Rec #: 260

 

 

 

 

 

 

double with REC#950

Inglis SC, Clark RA, McAlister FA et al. Structured telephone support or telemonitoring programmes for patients with chronic heart failure. Cochrane Database Syst Rev 2010; (8):CD007228.

Rec #: 490

 

 

 

 

 

 

double with Rec#1240

Pandor A. Home telemonitoring or structured telephone support programmes for patients with heart failure. Health Technol. Assess. 2013; 17(32).

Rec #: 1010

 

 

 

 

 

 

double with Rec#1010

Rychlik R., Rulhoff H. Socioeconomic relevance of selected treatment strategies in patients with chronic heart failure. Expert Rev. Pharmacoecon. Outcomes Res. 2005; 5(3):277-86.

Rec #: 1510

 

 

 

 

 

no

 

Kitsiou S, Pare G, Jaana M. Systematic reviews and meta-analyses of home telemonitoring interventions for patients with chronic diseases: a critical assessment of their methodological quality. J Med Internet Res 2013; 15(7):e150.

Rec #: 340

no

no

no

no

no

no

critical appraisal of systematic reviewing

Abu-Awwad R., Alkhatib Y., Bukannan A. et al. Telemonitoring in patients with heart failure: A single-center experience. J. Gen. Intern. Med. 2012; 27:S313.

Rec #: 1110

 

 

 

 

 

 

only abstract available

Clark A.L. Heart failure. Arch. Cardiol. Mex. 2011; 81(4):383-90.

Rec #: 1130

 

no

 

 

no

 

 

Cleland J.G.F., Coletta A.P., Buga L. et al. Clinical trials update from the American Heart Association Meeting 2010: EMPHASIS-HF, RAFT, TIM-HF, Tele-HF, ASCEND-HF, ROCKET-AF, and PROTECT. Eur. J. Heart Fail. 2011; 13(4):460-5.

Rec #: 1150

 

 

 

 

 

 

only abstract, refers to '130

Cleland JG, Coletta AP, Clark AL. Clinical trials update from the joint European Society and World Congress of Cardiology meeting: PEP-CHF, ACCLAIM and the HHH study. Eur J Heart Fail 2006; 8(6):658-61.

Rec #: 640

 

 

 

 

no

 

only abstract

Grustam AS, Severens JL, van Nijnatten J, Koymans R, Vrijhoef HJ. Cost-effectiveness of telehealth interventions for chronic heart failure patients: a literature review. Int J Technol Assess Health Care 2014; 30(1):59-68.

Rec #: 310

 

 

 

 

 

 

cost domain

Jaarsma T., Van Veldhuisen D.J., Gustafsson F., Arnold J.M.O. Heart failure management: How much COACH-ing is needed? (multple letters). Eur. Heart J. 2005; 26(3):314-5.

Rec #: 1520

no

no

no

no

no

no

letter to the editor

Oxberry SG, Johnson MJ. Review of the evidence for the management of dyspnoea in people with chronic heart failure. Curr Opin Support Palliat Care 2008; 2(2):84-8.

Rec #: 610

 

 

 

 

 

no

no informatio for cur, tec or leg

Seto E. Cost comparison between telemonitoring and usual care of heart failure: a systematic review. Telemed J E Health 2008; 14(7):679-86.

Rec #: 210

 

 

 

 

 

no

no informatio for cur, tec or leg

Stamp KD, Machado MA, Allen NA. Transitional care programs improve outcomes for heart failure patients (Provisional abstract). J Cardiovasc Nurs .

Rec #: 880

 

 

 

 

 

no

no informatio for cur, tec or leg

Stewart S. Comprehensive care in heart failure: Where to from here? Evid.-Based Healthc. Public Health 2005; 9(6):396-7.

Rec #: 1490

 

 

 

 

 

no

no informatio for cur, tec or leg

Van Spall H.G.C., Mytton O., Coppiens M., Shiga T., Haynes B., Connolly S. Comparative effectiveness of transitional care services in patients discharged from the hospital with heart failure (HF): A meta-analysis. Cardiology 2014; 128:470.

Rec #: 940

 

 

 

 

 

 

only abstract available

Whellan DJ, Adams S, Bowerman L. Review of advanced heart failure device diagnostics examined in clinical trials and the potential benefit from monitoring capabilities. Prog Cardiovasc Dis 2011; 54(2):107-14.

Rec #: 760

 

no

 

 

 

 

 

Winkler S., Koehler F. A Meta-Analysis of Remote Monitoring of Heart Failure Patients. J. Am. Coll. Cardiol. 2010; 55(14):1505-6.

Rec #: 1220

 

 

 

 

editorial

no

no informatio for cur, tec or leg

Zhang Y., Mabote T., Atkin P. et al. Outcome of patients discharged after an episode of worsening heart failure into a heart failure specialist service supported by home telemonitoring. Eur. J. Heart Fail. Suppl. 2012; 11:S35-S36.

Rec #: 1120

 

 

 

 

 

 

only abstract available

Duffy JR, Hoskins LM, Chen MC. Nonpharmacological strategies for improving heart failure outcomes in the community: a systematic review. J Nurs Care Qual 2004; 19(4):349-60.

Rec #: 240

other source

no

 

 

 

 

 

Casas J.P., Kwong J., Ebrahim S. Telemonitoring for chronic heart failure: not ready for prime time. Cochrane Database Syst Rev 2011; 2011:ED000008.

Rec #: 1370

 

 

 

 

 

 

Editorial

Metra M., Nodari S., Bardonali T., Milani P., Dei Cas L. Clinical trials update from the World Congress of Cardiology 2006. Expert Opin. Pharmacother. 2007; 8(6):881-9.

Rec #: 1290

 

no

 

 

 

 

 

Brignole M, Auricchio A, Baron-Esquivias G et al. 2013 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy: the  Task Force on cardiac pacing and resynchronization therapy of the European Society of Cardiology (ESC). Developed in collaboration with the European Heart Rhythm Association (EHRA). Eur Heart J 2013; 34(29):2281-329.

Rec #: 50

 

no

 

 

 

 

implantable devices overview

 

<< Health Problem and Current Use of the TechnologySafety >>